Goodwin

Partner

Molly Grammel is a partner in Goodwin’s Intellectual Property Litigation practice and is a member of the firm’s Life Sciences Disputes group. She has extensive federal trial experience in cutting-edge technology IP litigation that spans a diverse set of industries, including biologic and biosimilar drugs and artificial intelligence and machine learning. Molly is a go-to partner for managing complex, high stakes matters, including numerous representations involving products with greater than $1 billion annual US sales. Molly specializes in providing clients with business-focused counseling regarding litigation strategy and developing and executing substantive legal theories through stand-up roles in court. She is a practiced trial advocate who has had significant responsibility for presenting evidence and argument in trials before juries and judges in federal district courts across the country.

Molly also has extensive experience representing clients in appeals to Federal Circuit Courts, and representing patent owners and petitioners in post-grant challenges before the Patent Trial and Appeal Board of the United States Patent and Trademark Office.

University of Pennsylvania Law School (magna cum laude, Levy Scholarship)

University of California, Los Angeles (magna cum laude, Phi Beta Kappa, college honors program)